Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,956 public trials 1,252 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer

NCT05723562

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Albuquerque, New Mexico, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Acupuncture Pilot Study for Cancer-related Cognitive Function

NCT04007770

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +33 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)

NCT05239741

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Beijing Cancer hospital-Digestive Oncology ( Site 0001) Beijing, Beijing Municipality, China
  • Beijing Peking Union Medical College Hospital-Medical Oncology ( Site 0011) Beijing, Beijing Municipality, China
  • Tianjin Medical University Cancer Institute and Hospital-Gastric oncology ( Site 0019) Tianjin, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University ( Site 0051) Chongqing, Chongqing Municipality, China
View all 32 locations
View Trial Details
Active, Not Recruiting

Combination Immunotherapy in Colorectal Cancer

NCT05571293

Conditions
Colonic Diseases, Colorectal Neoplasms, Diabetes Mellitus, Insulin-Dependent, 12, +9 more
Locations
  • Weill Cornell Medicine/New York-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
  • Weill Cornell Medicine/NewYork Presbyterian - Queens Flushing, New York, United States
  • Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States
View Trial Details
Active, Not Recruiting

Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer

NCT04503694

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • Chirec Delta Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • UZAntwerpen Edegem, Belgium
View Trial Details

Related conditions